Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.440
-0.005 (-0.35%)
At close: Sep 26, 2025, 4:00 PM EDT
1.460
+0.020 (1.39%)
After-hours: Sep 26, 2025, 4:04 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.50 million as of September 26, 2025. Its market cap has decreased by -51.37% in one year.
Market Cap
8.50M
Enterprise Value
-8.03M
1-Year Change
-51.37%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.50M, a decrease of -55.08%. That is a compound annual growth rate of -21.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 8.50M | -52.44% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |